Essentia Health launches new Alzheimer’s detection test
September 9, 2025
The test detects amyloid plaques, abnormal brain protein deposits linked to cognitive impairment and a key indicator of Alzheimer’s.
The test detects amyloid plaques, abnormal brain protein deposits linked to cognitive impairment and a key indicator of Alzheimer’s.
Glioblastoma is a devastatingly effective brain cancer. Doctors can cut it out or blast it with radiation, but that only buys time. The cancer has an insidious ability to hide enough tumor cells in tissue around the tumor to allow it to return as deadly as ever.
Indiana University School of Medicine scientists have developed a new method that shifts the behavior of immunosuppressive cells in tumors, turning them from cancer protectors into tumor fighters.
In a landmark study of Hispanic and Latino adults, researchers at University of California San Diego School of Medicine have identified a link between self-reported cognitive decline and blood-based biomarkers, which could pave the way for a simple blood test to help diagnose Alzheimer’s disease and related dementias.
Roche announced today that it received CE mark approval for its port delivery platform containing its Susvimo therapeutic.
Tasso, a specialist in patient-centric blood collection, and SheMed, a UK-based women’s healthcare company, have teamed up to deliver safer, more personalised weight loss treatments through convenient at-home diagnostics.
A research team at UCLA, led by Professor Aydogan Ozcan, has introduced BlurryScope, a compact, cost-effective scanning microscope that combines simple optical hardware with advanced deep learning algorithms to assess HER2 status in breast cancer tissue samples.
A research team at Saarland University has demonstrated in a clinical study that a widely used anti-allergy nasal spray containing the active ingredient azelastine can significantly reduce the risk of infection with the SARS-CoV-2 virus. The results of the placebo-controlled trial involving 450 healthy participants have now been published in JAMA Internal Medicine.
Medtronic (NYSE: MDT)+
today announced major regulatory milestones for its MiniMed 780G automated insulin delivery system.
Professor Deng Hongkui’s team from the Peking University School of Life Sciences has made the first successful differentiation of human pluripotent stem cells into fully endocrine-subtype-complete islets.